BAY-1436032
BAY-1436032
Catalog No. M12757
BAY-1436032 (BAY1436032) is a potent, selective, orally available inhibitor of pan-mutant IDH1 with IC50 of 15 nM for both IDH1 R132H and R132C, respectively.
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-1436032
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Pusch S, et al. Acta Neuropathol. 2017 Apr;133(4):629-644. 2. Chaturvedi A, et al. Leukemia. 2017 Oct;31(10):2020-2028. 3. Gokul S, et al. CNS Neurol Disord Drug Targets. 2017;16(6):636-637.
molnova catalog
related products
-
Ivosidenib
A mutant-selective inhibitor of IDH1.
-
IDH305
IDH 305 (IDH305)?is a potent, selective, brain penetrant mutant IDH1 inhibitor with IC50 of 18 and 28 nM for IDH1 R132H and R132C.
-
Vorasidenib
Vorasidenib (AG-881) is a potent, selective and orally bioavailable pan-IDH (isocitrate dehydrogenase) mutant inhibitor for treatment of AML.
Cart
sales@molnova.com